Home/ Stocks/ SIGA

SIGA Technologies Inc.

SIGA XNAS

$3.05 -0.06 (-1.92%) ▼ 15-min delayed

Open

$3.15

High

$3.19

Low

$3.04

Volume

678.8K

Market Cap

$223.78M

About SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 49 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$6.24M	$-3,454,252	$-0.05
FY 2025	$94.57M	$23.28M	$0.33
Q3 2025	$2.62M	$-6,365,819	$-0.09
Q2 2025	$81.12M	$35.48M	$0.50

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for SIGA yet. Check out our latest market news or earnings calendar.

Get SIGA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on SIGA Technologies Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.